Abstract
Objective
To establish an orthotopic bladder cancer model bearing human bladder cancer for experimental research, and monitor tumor progression by magnetic resonance imaging (MRI).
Methods
The mucosa was mechanically damaged transurethrally under direct vision, and then human bladder cancer cell line T24 was inoculated into the bladders of BALB/c nude mice to establish orthotopic bladder cancer model. To find a suitable concentration of Gd-DTPA for this research. MRI was performed weekly to assess tumor growth, using Gd-DTPA as contrast agent. The pathologic morphology of the bladders and other specimens were observed with HE stain.
Results
All the 25 mice developed bladder cancer after inoculation. The best concentration of Gd-DTPA was 1.408 mg/mL. On MRI, no change in the bladders was observed on day 7 after inoculation, filling defect in the bladders, accordant to actual tumor size, was detected on days 14, 21 and 28. Pathologic examination showed that tumor grew in the mucosa or superficial muscle of bladder on day 7, confined in muscle layer on days 14–28, and invaded serosa on day 35.
Conclusion
Transurethrally damaged bladder mucosa under direct vision and instilled bladder cancer cell T24, we successfully established an orthotopic bladder cancer model. Tumor growth simulated the progression of human bladder cancer approximately. MRI was a reliable way for dynamic detection of murine orthotopic bladder tumor.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Mohanty NK, Malhotra V, Nayak RL, et al. Combined low-dose intravesical immunotherapy (BCG + interferon alpha-2b) in the management of superficial transitional cell carcinoma of the urinary bladder: a five-year follow-up. J Chemother, 2002, 14: 194–197.
Nogawa M, Yuasa T, Kimura S, et al. Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer. J Clin Invest, 2005, 115: 978–985.
Hoffman RM. Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs, 1999, 17: 343–359.
Bisson JF, Parache RM, Droulle P, et al. A new method of implanting orthotopic rat bladder tumor for experimental therapies. Int J Cancer, 2002, 102: 280–285.
Xiao Z, McCallum TJ, Brown KM, et al. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model. Br J Cancer, 1999, 81: 638–646.
Kikuchi E, Xu S, Ohori M, et al. Detection and quantitative analysis of early stage orthotopic murine bladder tumor using in vivo magnetic resonance imaging. J Urol, 2003, 170: 1375–1378.
Li C, Yan RP, Bao JC, et al. Characterization of a novel transplantable orthotopic murine xenograft model of a human bladder transitional cell tumor (BIU-87). Cancer Biol Ther, 2006, 5: 394–398.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the grants from the Talented Scholar Foundation of Jiangsu Province (No. RC2003094), the Sci-Tech research Foundation of Jiangsu Province (No. H200517), and “The Six Talent Peak” Project Foundation of Jiangsu Province (06-B-021).
Rights and permissions
About this article
Cite this article
Shenmin, Y., Duangai, W., Jianquan, H. et al. Establishment of orthotopic transplantation model of human bladder cancer and detection by MRI. Chin. -Ger. J. Clin. Oncol. 7, 51–54 (2008). https://doi.org/10.1007/s10330-007-0166-5
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10330-007-0166-5